AGEN

AGEN

USD

Agenus Inc. Common Stock

$3.980+0.140 (3.646%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$3.840

高値

$3.980

安値

$3.700

出来高

0.33M

企業ファンダメンタルズ

時価総額

126.8M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.46M

取引所

NCM

通貨

USD

52週レンジ

安値 $1.38現在値 $3.980高値 $7.34

関連ニュース

Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

もっと見る
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
BusinessWire

France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (NASDAQ:AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable

もっと見る
France Grants Reimbursed Compassionate Access (AAC) for Agenus' BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Earnings Call Transcripts

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)

もっと見る
Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call (Transcript)
PR Newswire

FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone

Federal budget cuts have put pressure on cancer research efforts in the United States, but private investment is helping to fill the gap, with...

もっと見る
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates Agenus with a Buy and maintains $23 price target.

もっと見る
HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $23 Price Target
BusinessWire

Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight

Webcast details updated from the August 11th release Webcast on Wednesday, August 27, 2025 at 4:00 p.m. EST Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in immuno-oncology, today announced an update to its